These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 24180534)

  • 1. New multipoint pacing technology for heart failure patients. Interview by Caroline Telfer.
    Betts T
    Future Cardiol; 2013 Nov; 9(6):771-3. PubMed ID: 24180534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in cardiac lead extraction. Interview by Caroline Telfer.
    Zaidi A
    Future Cardiol; 2013 Nov; 9(6):775-7. PubMed ID: 24180535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The polypill and the prevention of heart attacks and strokes by Caroline Telfer.
    Wald DS
    Future Cardiol; 2013 Jul; 9(4):465-6. PubMed ID: 23834685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interatrial conduction correlates with optimal atrioventricular timing in cardiac resynchronization therapy devices.
    Levin V; Razavi M; Coll R; Coles JA; Sambelashvili A
    Pacing Clin Electrophysiol; 2011 Apr; 34(4):443-9. PubMed ID: 21208227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of increased percentage of biventricular pacing to improve clinical outcomes in patients receiving cardiac resynchronization therapy.
    Gasparini M; Galimberti P; Ceriotti C
    Curr Opin Cardiol; 2013 Jan; 28(1):50-4. PubMed ID: 23196776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac resynchronization therapy for treatment of heart failure.
    Ho JK; Mahajan A
    Anesth Analg; 2010 Dec; 111(6):1353-61. PubMed ID: 21059745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac resynchronization therapy: expanding clinical indications and refining patient selection.
    Nery PB; Keren A; Birnie DH
    Curr Opin Cardiol; 2012 Mar; 27(2):137-42. PubMed ID: 22233979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac resynchronization therapy in mildly symptomatic heart failure: the earlier the better.
    Balmain S; McDonald MA
    Expert Rev Cardiovasc Ther; 2011 Sep; 9(9):1147-53. PubMed ID: 21932957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interventricular conduction time is associated with response to cardiac resynchronization therapy: interventricular electrical delay.
    D'Onofrio A; Botto G; Mantica M; La Rosa C; Occhetta E; Verlato R; Molon G; Ammendola E; Villani GQ; Bongiorni MG; Gelmini GP; Ciardiello C; Dicandia CD
    Int J Cardiol; 2013 Oct; 168(5):5067-8. PubMed ID: 23953259
    [No Abstract]   [Full Text] [Related]  

  • 10. To the Editor- Clinical potential of conduction system pacing versus biventricular pacing in heart failure: A trial sequential analysis and methodological comment.
    Romeiro P; Silva CR; Barroso D
    Heart Rhythm; 2024 Jul; 21(7):1182. PubMed ID: 38490604
    [No Abstract]   [Full Text] [Related]  

  • 11. Loss of cardiac resynchronization during DDD pacing: what is the mechanism?
    Tian Y; Zhang P; Li D; Guo J
    Int J Cardiol; 2013 Oct; 168(6):5455-7. PubMed ID: 24094770
    [No Abstract]   [Full Text] [Related]  

  • 12. Larger interventricular conduction time enhances mechanical response to resynchronization therapy.
    Padeletti L; Pieragnoli P; Ricciardi G; Perrotta L; Perini AP; Grifoni G; Ricceri I; Padeletti M; Lionetti V; Valsecchi S
    Pacing Clin Electrophysiol; 2013 Apr; 36(4):416-23. PubMed ID: 23305325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reply to the Editor- Clinical potential of conduction system pacing versus biventricular pacing in heart failure: A trial sequential analysis and methodological comment.
    Ferreira Felix I; Collini M; Fonseca R; Guida C; Armaganijan L; Healey JS; Carvalho G
    Heart Rhythm; 2024 Jul; 21(7):1182-1183. PubMed ID: 38490598
    [No Abstract]   [Full Text] [Related]  

  • 14. Benefits, unresolved questions, and technical issues of cardiac resynchronization therapy for heart failure.
    Rosanio S; Schwarz ER; Ahmad M; Jammula P; Vitarelli A; Uretsky BF; Birnbaum Y; Ware DL; Atar S; Saeed M
    Am J Cardiol; 2005 Sep; 96(5):710-7. PubMed ID: 16125501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Right ventricular lead positioning does not influence the benefits of cardiac resynchronization therapy in patients with heart failure and atrial fibrillation.
    Rönn F; Kesek M; Karp K; Henein M; Jensen SM
    Europace; 2011 Dec; 13(12):1747-52. PubMed ID: 21712261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac resynchronization therapy mechanisms in atrial fibrillation.
    Whinnett ZI; Francis DP
    Heart Fail Clin; 2013 Oct; 9(4):475-88, ix. PubMed ID: 24054480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transseptal conduction as an important determinant for cardiac resynchronization therapy, as revealed by extensive electrical mapping in the dyssynchronous canine heart.
    Strik M; van Deursen CJ; van Middendorp LB; van Hunnik A; Kuiper M; Auricchio A; Prinzen FW
    Circ Arrhythm Electrophysiol; 2013 Aug; 6(4):682-9. PubMed ID: 23873141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ventricular activation sequence during left ventricular pacing promotes QRS complex oversensing in the atrial channel.
    Jastrzebski M
    Pacing Clin Electrophysiol; 2011 Dec; 34(12):1682-6. PubMed ID: 21954967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac resynchronization therapy: what? Who? When? How?
    Cuculich PS; Joseph S
    Am J Med; 2011 Sep; 124(9):813-5. PubMed ID: 21854888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous monitoring of atrial fibrillation in heart failure.
    Herweg B; Barold SS; Steinberg JS
    Heart Fail Clin; 2013 Oct; 9(4):385-95, vii. PubMed ID: 24054472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.